Advanced in Patent Ductus Arteriosus

Dr. Waldemar A. Carlo

Neonatology
1700 6th Ave S Ste 9380, 
Birmingham, AL 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Advanced in Patent Ductus Arteriosus
1700 6th Ave S Ste 9380, 
Birmingham, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Waldemar Carlo is a Neonatologist in Birmingham, Alabama. Dr. Carlo is rated as an Advanced provider by MediFind in the treatment of Patent Ductus Arteriosus. His top areas of expertise are Premature Infant, Bronchopulmonary Dysplasia, Infant Respiratory Distress Syndrome, and Intraventricular Hemorrhage of the Newborn. Dr. Carlo is currently accepting new patients.

His clinical research consists of co-authoring 387 peer reviewed articles and participating in 19 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles and participated in 1 clinical trial in the study of Patent Ductus Arteriosus.

Specialties
Neonatology
Licenses
Pediatrics in AL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

1700 6th Ave S Ste 9380, Birmingham, AL 35233

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

19 Clinical Trials

National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) - A Collaborative Initiative to Improve Care of Children With Complex Congenital Heart Disease
National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) - A Collaborative Initiative to Improve Care of Children With Complex Congenital Heart Disease
Enrollment Status: Recruiting
Publish Date: June 19, 2025
Intervention Type: Other
Cycled Phototherapy: A Safer Effective Method to Control the Serum Bilirubin Of Extremely Premature Infants?
Cycled Phototherapy: A Safer Effective Method to Control the Serum Bilirubin Of Extremely Premature Infants?
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
Management of the Patent Ductus Arteriosus in Premature Infants Trial (PDA Trial)
Management of the Patent Ductus Arteriosus in Premature Infants Trial (PDA Trial)
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Other
Study Phase: Phase 3
Randomized Controlled Trial of Budesonide + Surfactant Versus Surfactant Alone in Extremely Preterm Infants (The Budesonide in Babies (BiB) Trial)
Randomized Controlled Trial of Budesonide + Surfactant Versus Surfactant Alone in Extremely Preterm Infants (The Budesonide in Babies (BiB) Trial)
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2025
Intervention Type: Drug
Study Drugs: Budesonide (Pulmicort Nebulizing Suspension), Surfactant (Poractant Alfa
Study Phase: Phase 3
Global Network for Women's and Children's Health Research Maternal Newborn Health Registry
Global Network for Women's and Children's Health Research Maternal Newborn Health Registry
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Other
Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2025
Intervention Type: Drug
Study Drugs: Morphine, Methadone
Study Phase: Phase 3
A Randomized Controlled Trial of the Effect of Hydrocortisone on Survival Without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22 - 26 Months of Age in Intubated Infants < 30 Weeks Gestation Age
A Randomized Controlled Trial of the Effect of Hydrocortisone on Survival Without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22 - 26 Months of Age in Intubated Infants < 30 Weeks Gestation Age
Enrollment Status: Completed
Publish Date: February 27, 2025
Intervention Type: Drug
Study Drug: Hydrocortisone
Study Phase: Phase 3
A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.
A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.
Enrollment Status: Completed
Publish Date: November 04, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Enrollment Status: Active_not_recruiting
Publish Date: October 30, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Randomized Controlled Trial of Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
A Randomized Controlled Trial of Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Device
Study Phase: Phase 2/Phase 3
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Enrollment Status: Completed
Publish Date: July 18, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?
Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?
Enrollment Status: Active_not_recruiting
Publish Date: March 22, 2024
Intervention Type: Procedure
Study Phase: Phase 3
Neurodevelopmental Effects of Donor Human Milk vs. Preterm Formula in Extremely Low Birth Weight (ELBW) Infants
Neurodevelopmental Effects of Donor Human Milk vs. Preterm Formula in Extremely Low Birth Weight (ELBW) Infants
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Biological, Dietary supplement
Study Drug: Donor Breast Milk
Study Phase: Phase 3
Cardboard Cot in Neonatal Thermoregulation: Prevention of Moderate or Severe Hypothermia in Preterm Infants Assigned to Open Crib
Cardboard Cot in Neonatal Thermoregulation: Prevention of Moderate or Severe Hypothermia in Preterm Infants Assigned to Open Crib
Enrollment Status: Withdrawn
Publish Date: October 26, 2021
Intervention Type: Other
Study Phase: Not Applicable
Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial in Prevention of Moderate or Severe Hypothermia in Preterm Infants Requiring at Least 1 Week of Incubator
Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial in Prevention of Moderate or Severe Hypothermia in Preterm Infants Requiring at Least 1 Week of Incubator
Enrollment Status: Withdrawn
Publish Date: October 26, 2021
Intervention Type: Other
Study Phase: Not Applicable
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC) - Specific Aim 3
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC) - Specific Aim 3
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC)
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC)
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: April 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Enrollment Status: Completed
Publish Date: March 11, 2019
View 18 Less Clinical Trials

387 Total Publications

A breath of life, and heartbeats for life: the science and soul of neonatal resuscitation.
A breath of life, and heartbeats for life: the science and soul of neonatal resuscitation.
Journal: Jornal de pediatria
Published: May 27, 2025
Similar Doctors
Advanced in Patent Ductus Arteriosus
Dr. Namasivayam Ambalavanan
Neonatology
Advanced in Patent Ductus Arteriosus
Dr. Namasivayam Ambalavanan
Neonatology
Birmingham, AL 
 (0.8 miles away)
205-996-2244
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Namasivayam Ambalavanan is a Neonatologist in Birmingham, Alabama. Dr. Ambalavanan is rated as an Elite provider by MediFind in the treatment of Patent Ductus Arteriosus. His top areas of expertise are Bronchopulmonary Dysplasia, Premature Infant, High Blood Pressure in Infants, Cerebral Hypoxia, and Gastrostomy. Dr. Ambalavanan is currently accepting new patients.

Advanced in Patent Ductus Arteriosus
Dr. David A. Randolph
Neonatology
Advanced in Patent Ductus Arteriosus
Dr. David A. Randolph
Neonatology
619 South 19th Street, Nhb 525, 
Birmingham, AL 
 (0.2 miles away)
205-934-4680
Languages Spoken:
English
See accepted insurances

David Randolph is a Neonatologist in Birmingham, Alabama. Dr. Randolph is rated as an Experienced provider by MediFind in the treatment of Patent Ductus Arteriosus. His top areas of expertise are Patent Ductus Arteriosus, Atresia of Small Intestine, Gastroschisis, Congenital Unilateral Pulmonary Hypoplasia, and Gastrostomy.

Experienced in Patent Ductus Arteriosus
Dr. Colm P. Travers
Neonatology | Pediatrics
Experienced in Patent Ductus Arteriosus
Dr. Colm P. Travers
Neonatology | Pediatrics
1700 6th Ave S, 
Birmingham, AL 
 (0.2 miles away)
205-934-3411
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Colm Travers is a Neonatologist and a Pediatrics provider in Birmingham, Alabama. Dr. Travers is rated as a Distinguished provider by MediFind in the treatment of Patent Ductus Arteriosus. His top areas of expertise are Premature Infant, Infantile Apnea, Bronchopulmonary Dysplasia, and Cerebral Hypoxia. Dr. Travers is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Carlo's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 12 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile